Ethasyl T 500 mg/250 mg Tablet is a combination medication containing Tranexamic Acid (500 mg) and Ethamsylate (250 mg), primarily used to prevent and control excessive bleeding. Tranexamic Acid is an antifibrinolytic agent that works by inhibiting the breakdown of fibrin clots, thereby promoting clot stability and reducing bleeding. Ethamsylate enhances capillary endothelial resistance and improves platelet adhesion, which further aids in reducing bleeding tendencies. This tablet is commonly prescribed for various conditions such as menorrhagia, postoperative bleeding, dental extractions, and other hemorrhagic disorders where controlling blood loss is essential. It is also beneficial in managing bleeding associated with surgical procedures and trauma. Ethasyl T is generally well-tolerated, but it should be used under medical supervision, especially in patients with a history of thromboembolic disorders or hypersensitivity to its components. The dosage and duration of treatment depend on the severity of bleeding and the underlying condition. Patients are advised to follow their healthcare provider’s instructions carefully to ensure optimal efficacy and safety. This combination therapy offers a synergistic approach to managing bleeding by targeting multiple pathways involved in hemostasis.